Stephens Inc Atai Life Sciences N.V. Transaction History
Stephens Inc
- $7.43 Billion
- Q3 2025
A detailed history of Stephens Inc transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Stephens Inc holds 29,380 shares of ATAI stock, worth $188,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,380Holding current value
$188,619% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
115Shares Held
31.6MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$49.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$34.9 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$22.4 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$17 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$8.39 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $1.06B
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...